WJWM
NWBO
Williams Jones Wealth Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.48K | Hold |
27,000
| – | – | ﹤0.01% | 500 |
|
2025
Q1 | $6.17K | Hold |
27,000
| – | – | ﹤0.01% | 492 |
|
2024
Q4 | $7.42K | Sell |
27,000
-8,000
| -23% | -$2.2K | ﹤0.01% | 494 |
|
2024
Q3 | $11.2K | Hold |
35,000
| – | – | ﹤0.01% | 532 |
|
2024
Q2 | $14.9K | Sell |
35,000
-5,000
| -13% | -$2.13K | ﹤0.01% | 510 |
|
2024
Q1 | $20.8K | Sell |
40,000
-4,000
| -9% | -$2.08K | ﹤0.01% | 535 |
|
2023
Q4 | $30.8K | Hold |
44,000
| – | – | ﹤0.01% | 530 |
|
2023
Q3 | $40K | Hold |
44,000
| – | – | ﹤0.01% | 533 |
|
2023
Q2 | $25K | Hold |
44,000
| – | – | ﹤0.01% | 516 |
|
2023
Q1 | $27.5K | Hold |
44,000
| – | – | ﹤0.01% | 551 |
|
2022
Q4 | $34.5K | Buy |
44,000
+5,000
| +13% | +$3.92K | ﹤0.01% | 546 |
|
2022
Q3 | $28K | Hold |
39,000
| – | – | ﹤0.01% | 556 |
|
2022
Q2 | $25K | Hold |
39,000
| – | – | ﹤0.01% | 558 |
|
2022
Q1 | $27K | Hold |
39,000
| – | – | ﹤0.01% | 518 |
|
2021
Q4 | $27K | Hold |
39,000
| – | – | ﹤0.01% | 491 |
|
2021
Q3 | $50K | Hold |
39,000
| – | – | ﹤0.01% | 477 |
|
2021
Q2 | $57K | Hold |
39,000
| – | – | ﹤0.01% | 485 |
|
2021
Q1 | $58K | Sell |
39,000
-11,000
| -22% | -$16.4K | ﹤0.01% | 481 |
|
2020
Q4 | $76K | Hold |
50,000
| – | – | ﹤0.01% | 457 |
|
2020
Q3 | $39K | Hold |
50,000
| – | – | ﹤0.01% | 427 |
|
2020
Q2 | $17K | Hold |
50,000
| – | – | ﹤0.01% | 413 |
|
2020
Q1 | $8K | Hold |
50,000
| – | – | ﹤0.01% | 381 |
|
2019
Q4 | $11K | Hold |
50,000
| – | – | ﹤0.01% | 441 |
|
2019
Q3 | $12K | Buy |
+50,000
| New | +$12K | ﹤0.01% | 424 |
|